Skin News and Research

RSS

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Unilife Medical Solutions Limited today announced the filing of patent applications in the United States ("US") for a new ready-to-fill syringe product to be marketed as the Unifill™ Select. Unilife is confident that this new pipeline product, which is to be primarily targeted for use with vaccines, can further expand the Company's ability to penetrate the pharmaceutical market for prefilled syringes.

25 Nov 2009

Pari Beauty Professional Artistry, a comprehensive line of color cosmetics and advanced skin care

Introducing Pari Beauty Professional Artistry, a comprehensive line of color cosmetics and advanced skin care dedicated to providing prestige formulas at irresistible prices.

25 Nov 2009

Young girls not influenced by thin, beautiful princesses in animated children's movies

Even before they start school, many young girls worry that they are fat. But a new study suggests watching a movie starring a stereotypically thin and beautiful princess may not increase children's anxieties.

25 Nov 2009

Study: GSTP gene protects against bowel cancer

CANCER RESEARCH UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.

25 Nov 2009

Researchers develop new device to detect skin cancer

Researchers at Ben-Gurion University of the Negev are developing a new device that detects cancerous skin tumors, including melanomas that aren't visible to the naked eye.

25 Nov 2009

Community-based program proves to be successful in reducing skin infections in Australian aboriginal children

A community-based program aimed at reducing the burden of skin disease across remote communities in Australia's Northern Territory has been successful according to a study published November 24 in the open-access journal PLoS Neglected Tropical Diseases.

25 Nov 2009

People with severe EBS at increased risk of skin cancer, say scientists

UK scientists have discovered the link between people with the skin blistering disease Epidermolysis Bullosa Simplex-Dowling-Meara, (EBS -DM) - and tumour growth, according to research published in Journal of Investigative Dermatology today (Monday).

25 Nov 2009

Worldwide collaboration leads to treatment for rare skin disorder

Researchers at Huntsman Cancer Institute, in collaboration with a worldwide group of physicians and scientists, have discovered a remarkable treatment for a rare, yet debilitating, skin condition.

25 Nov 2009

Merit Web Health Award for MannatechScience.org

Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced today its educational Web site, MannatechScience.org, has received a merit Web Health Award.

24 Nov 2009

Delcath Systems sponsors "Regional Therapeutic Options for Metastatic Melanoma" symposium

Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, recently sponsored a Satellite Symposium at the World Meeting of Melanoma/Skin Cancer Centers in Berlin, Germany. The session, titled "Regional Therapeutic Options for Metastatic Melanoma," was held on Friday, November 20 and featured updates and observations on a variety of current therapies by clinical leaders in the field.

24 Nov 2009

About Face Acne Foundation to provide best-in-class therapy for indigent acne patients

Acne is a serious medical condition. More than 40 percent of mid-teens and adolescents have either acne or acne scarring requiring professional treatment by a dermatologist. Unfortunately, nationwide statistics show that only 11 percent of patients receive treatment.

24 Nov 2009

BioAlliance Pharma's AMEP biotherapy reduces both tumour growth and tumour angiogenesis

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented preclinical results on its new biotherapy, AMEP™ for advanced and metastatic melanoma at the ESGCT (European Society of Gene and Cell Therapy) in Hannover (November 21 to 25, 2009).

24 Nov 2009

LFAGW celebrates 35th anniversary

The Lupus Foundation of America Greater Washington Chapter (LFAGW) will celebrate 35 years of success providing free day-to-day education, advice and resources for the 75,000+ people with lupus and their families in the greater D.C. area.

24 Nov 2009

New computational tool may aid surgeons plan for life-saving pediatric operation

A team of researchers at the University of California, San Diego and Stanford University has developed a way to simulate blood flow on the computer to optimize surgical designs. It is the basis of a new tool that may help surgeons plan for a life-saving operation called the "Fontan" surgery, which is performed on babies born with severe congenital heart defects.

24 Nov 2009

Vitamin D: A multi-purpose nutrient for overall health

A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic."

24 Nov 2009

Horizon Health International, Exmovere Holdings enter into a marketing and distribution agreement

HORIZON HEALTH INTERNATIONAL CORP. is pleased to announce that it has executed a Definitive Agreement with Exmovere Holdings Inc. of McLean, Virginia USA (Exmovere). Under the terms of the Agreement Horizon will pay Exmovere a total of two million dollars over a one year period for the exclusive rights to market and distribute their products in Canada for a 15 year term.

23 Nov 2009

Provectus Pharmaceuticals announces Phase 1 interim study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends to Phase 1 survival data.

23 Nov 2009

Raptor Pharmaceutical announces results of NGX426 clinical trial

Raptor Pharmaceutical Corp. today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco.

23 Nov 2009

OEPA reports substantial reduction of river blindness in six endemic countries

A regional initiative launched in the 1990s to eliminate onchocerciasis (river blindness) in the Americas has substantially reduced the prevalence of the disease in recent years, as evidenced by a 31% decrease in the number of individuals requiring mass drug administration in six endemic countries. Results were reported today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

23 Nov 2009

Children exposed to pollution and indoor allergens face increased risk of asthma

Children who are exposed to high levels of traffic-related pollution and high levels of indoor endotoxin early in life have six times the risk of developing persistent wheezing by age three than children exposed to low levels of traffic and indoor-related pollutants, according to new research from the University of Cincinnati College of Medicine.

23 Nov 2009

Skin News and Research

Unilife Medical Solutions files a patent application for its Unifill Select ready-to-fill syringe

Pari Beauty Professional Artistry, a comprehensive line of color cosmetics and advanced skin care

Young girls not influenced by thin, beautiful princesses in animated children's movies

Study: GSTP gene protects against bowel cancer

Researchers develop new device to detect skin cancer

Community-based program proves to be successful in reducing skin infections in Australian aboriginal children

People with severe EBS at increased risk of skin cancer, say scientists

Worldwide collaboration leads to treatment for rare skin disorder

Merit Web Health Award for MannatechScience.org

Delcath Systems sponsors "Regional Therapeutic Options for Metastatic Melanoma" symposium

About Face Acne Foundation to provide best-in-class therapy for indigent acne patients

BioAlliance Pharma's AMEP biotherapy reduces both tumour growth and tumour angiogenesis

LFAGW celebrates 35th anniversary

New computational tool may aid surgeons plan for life-saving pediatric operation

Vitamin D: A multi-purpose nutrient for overall health

Horizon Health International, Exmovere Holdings enter into a marketing and distribution agreement

Provectus Pharmaceuticals announces Phase 1 interim study data of PV-10 for metastatic melanoma

Raptor Pharmaceutical announces results of NGX426 clinical trial

OEPA reports substantial reduction of river blindness in six endemic countries

Children exposed to pollution and indoor allergens face increased risk of asthma

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News